Carboxypeptidase M (CPM) is a membrane-bound zincdependent protease that cleaves C-terminal basic residues, such as arginine or lysine, from peptides/proteins. We examined whether CPM is expressed by hematopoietic and stromal cells and could degrade stromal cell-derived factor (SDF)-1␣, a potent chemoattractant for hematopoietic stem/ progenitor cells (HSPC). We found that (a) CPM transcript is expressed by bone marrow (BM) and mobilized peripheral blood CD34
INTRODUCTION
Carboxypeptidase M (CPM) belongs to the family of zincdependent enzymes that catalyze the hydrolysis of the C-terminal peptide bond in peptides and proteins. They have been implicated in protein digestion, modulation of hormone activities, thrombosis, hemostasis, and inflammation. On the basis of structural arrangement, substrate specificity, and biological function, carboxypeptidases (CP) are broadly classified into a digestive/pancreatic subfamily (CPA1-CPA6, CPB, and CPU) and a regulator subfamily (CPE/H, CPN, CPD, CPZ, CPX1, CPX2, and CPM). CPM, CPE/H, CPN, CPD, CPZ, CPB, and CPU cleave C-terminal arginine or lysine, albeit with different specificities [1, 2] . Unique to CPM is its binding via a glycosylphosphatidylinositol (GPI) glycan anchor [3] to the plasma membranes of various cell types (lung endothelial cells, alveolar macrophages, ovarian follicles, trophoblasts, placental and kidney microvilli, blood vessels, and nerves), although a soluble form of CPM has also been demonstrated (seminal plasma, urine, and amniotic fluid) [4, 5] . The physiological role of CPM has not been clearly defined; however, its presence on macrophages and endothelial and epithelial cells [6 -8] makes it a prime candidate for the regulation or processing of peptides generated during inflammation, such as complement anaphylatoxins (C3a, C4a, and C5a) and kinins (also described as substrates for CPN [9] and possibly CPU [10] ). ProCPU and CPN are not membrane-bound and are produced in the liver and secreted into the bloodstream [11] . In this work we focused on CPM because this membrane-bound CP is ideally situated to elicit a more targeted activity at local tissue sites [12] than soluble CPN or CPU. CPM is known to cleave C-terminal lysine or arginine of peptides and proteins [4] , and therefore we investigated whether the chemokine stromal cell-derived factor (SDF)-1␣ (CXCL12), which has lysine at the carboxy (C) terminus, is a substrate for CPM. In the bone marrow (BM) microenvironment, SDF-1␣ is produced mainly by endothelial cells, fibroblastic cells, and osteoblasts. It provides a potent retention signal for hematopoietic stem/progenitor cells (HSPC), mediated via the CXCR4 receptor expressed on these cells [13, 14] . Until recently, research focused on two human SDF-1 isoforms, SDF-1␣ (1-68) and SDF-1␤ (1-72), with SDF-1␤ having an additional four amino acid residues at the C terminus. Human SDF-1␣ is composed of three distinct structural regions: an N terminus, a central core region of three antiparallel ␤-sheets, and a C-terminal helix. Previous studies have demonstrated the essential role of the N terminus, especially the first nine residues, as the major site for direct interaction with the CXCR4 receptor and subsequent signal transduction [15] . However, the functional role of the C terminus has been much less defined and appreciated. When exposed to human serum, fulllength SDF-1␣ (1-68) undergoes rapid processing at the C terminus to produce des-lys SDF-1␣ (1-67) [16, 17] . This C-terminal cleavage reduces the ability of SDF-1␣ to bind to heparin and cells and to stimulate chemotaxis [17] . The Nterminal cleavage of SDF-1␣ is effected by various enzymes such as matrix metalloproteinases (MMPs) [18] , CD26/dipeptidylpeptidase (DPP) IV [19] , and neutrophil serine proteases [20] or elastases [21] , generating distinct truncated forms that are functionally inactive. These enzymes are thought to be released during granulocyte-colony-stimulating factor (G-CSF)-induced HSPC mobilization, leading to a highly proteolytic microenvironment in the BM [22, 23] . It has been postulated that disruption of SDF-1/CXCR4 signaling is a key step in the release of HSPC from the BM to peripheral blood (PB) during mobilization [24, 25] . Nevertheless, mice deficient in neutrophil proteases exhibit normal HSPC mobilization in response to G-CSF [26] , and this may be partly explained by the existence of other proteases that have compensatory activities. In this work we investigated whether (a) CPM is expressed by various cells of the BM, (b) the mobilizing agent G-CSF upregulates it, and (c) CPM catalyzes the cleavage of SDF-1␣.
MATERIALS AND METHODS

Cell Lines and Hematopoietic and Stromal Cells
The hematopoietic cell lines THP-1 (monocytic), KG-1, KG-1a, HL-60 (all myeloid), Jurkat, and Raji (both lymphoid) were obtained from the American Type Culture Collection (Rockville, MD, http://www.atcc.org) and grown in RPMI medium supplemented with 10% fetal calf serum (FCS). BM samples were collected from healthy, unrelated bone marrow donors, mobilized peripheral blood (mPB) samples from patients diagnosed with non-Hodgkin's lymphoma who had undergone G-CSF mobilization at the Cross Cancer Institute (Edmonton, AB, Canada), and cord blood (CB) samples from healthy, full-term newborn infants (with the mothers' informed consent), all in accordance with the guidelines approved by the University of Alberta Health Research Ethics Board. Lightdensity mononuclear cells (MNC) were separated by centrifugation using a 60% Percoll density gradient (1.077 g/ml; Amersham Biosciences, Uppsala, Sweden, http://www.amersham.com). Polymorphonuclear cells (PMN) were obtained from whole blood after density gradient centrifugation using Lympholyte-poly (1.113 g/ml; CedarLane, Hornby, ON, Canada, http://www.cedarlanelabs.com) according to the manufacturer's instructions. CD34 ϩ cells were isolated from the light-density MNC interphase using the Miltenyi MACS system (Miltenyi Biotec, Auburn, CA, http://www.miltenyibiotec.com) according to the manufacturer's instructions and as we described previously [27] . For some experiments, CD34 ϩ cells were ex vivo expanded in a serum-free liquid culture system, supplemented with the appropriate recombinant human (rh) cytokines and growth factors, into myeloid (colony forming unit-granulocyte/macrophage [CFU-GM[, using granulocyte-macrophage colony-stimulating factor and interleukin [IL]-3), erythroid (blast-forming unit-erythroid [BFU-E], using erythropoietin and stem cell factor), and megakaryocytic (colony forming unit-megakaryocyte [CFU-Meg], using thrombopoietin and IL-3) lineages, as we described previously [28] . Ex vivo expansion cultures were incubated at 37°C in a fully humidified atmosphere supplemented with 5% CO 2 for up to 11 days. Cells were analyzed by flow cytometry, confocal microscopy, and gel-based reverse transcription (RT)-polymerase chain reaction (PCR) for CPM expression, as described below.
Mesenchymal stem cells (MSC) were established from BM or CB as we previously described [29] , and colony-forming unitfibroblast (CFU-F) cultures were from BM buffy coat cells, as we also described [30] . Human umbilical vein endothelial cells (HUVEC) were cultured on gelatin-coated flasks in medium consisting of M199, 10 mM L-glutamine, 250 IU/ml penicillin-streptomycin, 20% FCS (all from Invitrogen, Burlington, ON, Canada, http://www.invitrogen.com), and endothelial cell growth supplement (Collaborative Biomedical, Bedford, MA, http://www. bdbiosciences.com). Cells were grown almost to confluence, incubated for 24 hours in serum-free Iscove's modified Dulbecco's medium (IMDM) at 37°C in 5% CO 2 , trypsinized, and analyzed by RT-PCR for CPM expression.
In some experiments, CD34 ϩ cells, MNC, PMN, and CFU-F stromal cells were incubated in serum-free IMDM with or without 100 ng/ml rhG-CSF (Filgrastim; Amgen, Thousand Oaks, CA, http://www.amgen.com) for 24 -48 hours at 37°C. After the incubation period, some cells were set aside for flow cytometry, and the remaining cell pellets were used for RNA isolation and RT-PCR or lysed and analyzed by Western blot for CPM expression.
RT-PCR Analysis of CPM Expression
RNA was extracted from cell pellets using TRIZOL (Gibco-BRL, Gaithersburg, MD, http://www.gibcobrl.com), and RT-PCRs were carried out using the following primer sequences for human CPM [31] (Integrated DNA Technologies, Inc., San Diego, http://www. idtdna.com): CPM sense, 5Ј-GCCTGATGATGATGTTTTTC-3Ј; CPM antisense, 5Ј-TGGTGATGTGGGTTGAGTTT-3Ј. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal mRNA control. For all samples, PCR was run for 10 cycles (heat denaturation step at 94°C for 45 seconds, primer annealing step at 55°C for 45 seconds, and primer extension at 72°C for 1 minute), after which GAPDH primers were added and PCR was continued for 30 more cycles. PCR products (306 base pairs [bp] for GAPDH and 715 bp for CPM) were electrophoresed through 2.0% agarose gels containing 0.1 g/l ethidium bromide, and gels were visualized under UV light and photographed using a Kodak DC120 digital camera (Kodak, Rochester, NY, http://www.kodak.com) or the FluorChem imaging system (Alpha Innotech, San Leandro, CA, http://www.alphainnotech.com). Densitometric analysis was carried out using the AlphaEase FCr image analysis software (Alpha Innotech).
Fluorescence-Activated Cell Sorting Analysis
Ex vivo-expanded hematopoietic precursors were evaluated by flow cytometry for expression of differentiation markers glycophorin A (BFU-E), CD33 (CFU-GM), and CD41 (CFU-Meg) using antibodies from Beckman Coulter (Jersey City, NJ, http://www. beckmancoulter.com) or BD Pharmingen (San Diego, http://www. bdbiosciences.com/index_us.shtml). Hematopoietic cell lines (THP-1, KG-1, KG-1a, HL-60, Jurkat, and Raji), BM and PB CD34 ϩ cells, MNC, PMN, and hematopoietic precursor cells were stained with a 1:250 dilution of mouse monoclonal anti-CPM antibody (NCL-CPMm; Novocastra Ltd., Newcastle upon Tyne, U.K., http://www.novocastra.co.uk) for 45 minutes at 4°C followed by staining with a 1:200 dilution of secondary antibody goat antimouse IgG (Alexa Fluor-488, A11001; Invitrogen) for 30 minutes at 4°C. The percentage of stained cells was compared with that of a mouse IgG1 isotype-matched control (Dako, Mississauga, ON, Canada, http://www.dako.com) using the FACScan flow cytometer and analyzed with FCS Express v3 software (De Novo Software, Thornhill, ON, Canada, http://www.denovosoftware.com).
anti-mouse Alexa Fluor-488 (Invitrogen). Finally, they were mounted in ProLong antifade reagent (Invitrogen) and examined using an LSM510 laser scanning confocal microscope (Carl Zeiss, Jena, Germany, http://www.zeiss.com).
Western Blot
Cell pellets were sonicated in lysis buffer (1% [vol/vol] Triton, 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM Na 3 VO 4 , 5 g/ml leupeptin, 5 g/ml aprotinin, and 0.5 g/ml pepstatin A, pH 7.3; all reagents from Sigma-Aldrich, Oakville, ON, Canada, http://www. sigmaaldrich.com), and the lysates were clarified by centrifugation at 14,000 rpm for 10 minutes at 4°C. Protein concentration was determined using the Bio-Rad protein assay according to the manufacturer's instructions (Bio-Rad, Hercules, CA, http://www.biorad.com), and equal amounts of proteins were loaded alongside molecular weight markers (Precision Plus Protein Standards; BioRad). Samples were resolved in a 10% polyacrylamide gel under reducing conditions and transferred to a polyvinylidene fluoride membrane. Following blockage with 5% fat-free dried milk (in Tris-buffered saline and 0.05% Tween 20), the membrane was probed with monoclonal mouse CPM antibody (NCL-CPMm; Novocastra) at 1:200 dilution and then with a 1:2,000 dilution of secondary antibody (Immunopure goat anti-mouse, peroxidase-conjugated IgG; Pierce, Rockford, IL, http://www.piercenet.com). Chemiluminescence detection was performed using the Supersignal West Pico Chemiluminescence system (Pierce), and densitometric analysis of the blots was carried out using the AlphaEase FCr image analysis software (Alpha Innotech).
Mass Spectrometric Analysis of CPM-Mediated Hydrolysis of SDF-1␣ (1-68)
The recombinant CPM used in this study was purified from the supernatant of Pichia pastoris yeast strain X33 expressing CPM, which was cloned using the pPICZ␣ expression vector as previously described [32] . To study the kinetics of CPM-mediated hydrolysis, SDF-1␣ (1-68) (Peprotech, Rocky Hill, NJ, http://www.peprotech. com), in a final concentration of 5 M, was mixed with CPM (final concentration, 15 nM) and incubated at 37°C in the presence of 100 mM HEPES at pH 7.4. At certain time intervals, aliquots were withdrawn and quenched with 1% solution of trifluoroacetic acid. C18 Zip Tips (Millipore, Billerica, MA, http://www.millipore.com) were used to desalt the samples. Elution was performed stepwise with 20 l of 30% and 10 l of 50% acetonitrile in 0.1% acetic acid. The mixture of this combined elution was introduced to an Esquire ESI Ion Trap mass spectrometer (Bruker, Bremen, Germany, http:// www.bruker.com) using a syringe pump at 3 l/minute. The instrument was used in a normal range (620 -1,200 m/z) and resolution setting (1 mass unit at 3,000 m/z), optimized on an m/z value near the most abundant ion of the intact peptide. The spectra were deconvoluted, and the concentrations of the intact and truncated peptides were calculated from their relative abundance.
Chemotaxis Assay
Cells (1.5 ϫ 10 6 cells per milliliter of IMDM containing 0.1% bovine serum albumin [BSA]) were loaded in the upper compartments of Boyden chambers and incubated (at 37°C and 5% CO 2 ) for 3 hours. The compartments were separated by polycarbonate membrane filters (13-mm diameter, 8-m pore size; VWR, Mississauga, ON, Canada, http://www.vwrcanlab.com). The lower compartments contained serum-free medium with or without 10, 20, or 200 ng/ml rh SDF-1␣ or 10 ng/ml rh SDF-1␤ (both from Peprotech), which had been treated or not with recombinant CPM. Preincubation of 5 M SDF-1 with 20 nM CPM was carried out for 1 hour at 37°C. For some experiments CPM was preincubated with a 5 M concentration of the carboxypeptidase inhibitor DL-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid (MERGETPA; EMD Biosciences, San Diego, http://www.emdbiosciences.com) for 10 minutes at 37°C prior to the chemotaxis assay. In another set of experiments, cells highly expressing CPM (THP-1 cells) were preincubated with 5 M MERGETPA (for 30 minutes at 37°C prior to the assay) and allowed to migrate toward 3 ng/ml full-length SDF-1␣ (1-68) or synthetic des-lys SDF-1␣ (1-67) (Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada, http:// www.brc.ubc.ca). Percentage of migration was calculated from the ratio of the number of cells recovered from the lower compartment to the total number of cells loaded. Each experiment was carried out at least three independent times in triplicate or quadruplicate. Arithmetic means and SDs were calculated, and statistical significance was defined as p Յ .05 using the nonparametric Mann-Whitney test.
Competitive Binding Assay with the Anti-CXCR4 Antibody 12G5
To compare the binding efficacy to CXCR4 of SDF-1␣ (1-68) and CPM-treated SDF-1␣ (1-67), a competitive binding assay was used [33] . Briefly, cells highly expressing CXCR4 (Jurkat cells) were washed three times with cold buffer (phosphate-buffered saline, 0.1% BSA), and 4 ϫ 10 5 cells were incubated with 15 l of anti-CXCR4-PE (clone 12G5; BD Pharmingen) and various concentrations (0, 20, 200, and 2,000 ng/ml) of SDF-1␣ (1-68) or CPM-treated SDF-1␣ (for 45 minutes at 4°C in the dark). For the CPM treatment, 5 M SDF-1␣ (1-68) was incubated with 50 U/l of recombinant CPM for 1 hour at 37°C, under which conditions full-length SDF-1␣ is almost fully degraded to des-lys SDF-1␣, as described below. The stained cells were then washed three times and immediately analyzed by fluorescence-activated cell sorting (FACS). Mean fluorescence intensity of bound antibody (12G5) was plotted versus SDF-1␣ concentration.
RESULTS
CPM Is Expressed in Hematopoietic Cell Lines
As surface CPM had earlier been shown to be expressed in B-lineage malignant primary cells and cell lines [34] , we decided to investigate its expression at the gene level in other hematopoietic cell lines using semiquantitative gel-based RT-PCR. These cell lines showed variable CPM gene expression, with the monocytic THP-1 cell line expressing the highest, followed by the myeloid KG-1 cell line and the lymphoid Jurkat T-cell line. Expression of CPM transcript was absent in the lymphoid Raji and the myeloid HL-60 cell lines (Fig. 1A) . Surface protein expression of CPM in these cell lines (as examined by flow cytometry and confocal microscopy; Fig. 1B ) was consistent with their gene expression. Particularly in THP-1 cells, which strongly express CPM, confocal microscopy demonstrated its localization on the plasma membrane surface. Interestingly, KG-1a cells, which are morphologically, cytochemically, and functionally less mature than their parental KG-1 cells, expressed hardly any CPM on their surface (Fig. 1C) .
CPM Is Expressed in Primary Hematopoietic and Nonhematopoietic Cells
We next investigated the expression of CPM in the various hematopoietic and stromal cells that comprise the BM microenvironment, using THP-1 cells as a positive control. In particular, we were interested in ascertaining whether CPM expression changes with hematopoietic cell maturation. We found that CPM transcript is expressed by both hematopoietic cells (CD34 ϩ cells from mPB, BM, and CB and MNC from BM and mPB) and nonhematopoietic cells (MSC, HUVEC, and CFUfibroblastic cells) ( Fig. 2A) . Furthermore, myeloid, erythroid and megakaryocytic progenitors expanded ex vivo from CD34 ϩ cells from mPB, BM, and CB also expressed the CPM gene (Fig. 2B) . The presence of CPM protein in BM CD34 ϩ cells was confirmed by flow cytometry, and its surface localization was demonstrated by confocal microscopy. CPM protein was also expressed in fibroblastic cells (Fig. 2C) . We found that surface expression of CPM increased with maturation during ex vivo expansion, particularly of CFU-GM and CFU-Meg progenitors from CB CD34 ϩ cells. On day 11, in 96% pure populations of CFU-GM, nearly half of the cells expressed CPM. Similarly, in cells expanded toward the CFU-Meg lineage (75% expressing the CD41 marker), 50% of cells expressed CPM. In contrast, in BFU-E progenitors (84% expressing the glycophorin A marker), only 11% expressed CPM (Fig. 2D) .
G-CSF Upregulates CPM Expression in MNC and PMN
Next we determined whether the mobilizing agent G-CSF has any effect on the gene and protein expression of CPM. We incubated CD34 ϩ cells, MNC, PMN, and stromal cells for 24 -48 hours with 100 ng/ml G-CSF and examined CPM gene expression (by semiquantitative RT-PCR), total protein expression (by Western blot), and surface expression (by flow cytometry). We found that G-CSF upregulates CPM at the gene and protein levels in mature myeloid cells (MNC [ Fig. 3A] and PMN [ Fig. 3B]) but not in immature CD34
ϩ cells or stromal cells (Fig. 3C) . The Western blot was run alongside protein standards, which revealed a molecular weight of approximately 62 kDa for CPM. Consistently, Western blotting (data not shown) and flow cytometric analysis showed no discernible effect of G-CSF on the expression of CPM on mPB CD34 ϩ cells (Fig. 3C) . Moreover, we found that in the leukapheresis products from patients mobilized with G-CSF, CPM was strongly expressed in the granulocyte-gated population (Fig. 3D) , an observation consistent with in vitro G-CSF stimulation of normal PMN (Fig. 3B) .
SDF-1␣ Is Cleaved by CPM
Having demonstrated the production of CPM by hematopoietic and stromal cells and its upregulation in MNC and PMN by G-CSF in vitro and in vivo in G-CSF-mobilized PMN, we next investigated whether CPM cleaves SDF-1␣. SDF-1␣ is produced in abundance in the BM microenvironment, and its degradation is implicated in the mobilization of HSPC. We incubated intact SDF-1␣ (1-68) with CPM and monitored the formation of des-lys SDF-1␣ (1-67) by determining the ratio of intact/cleaved peptide at various time intervals using mass spectrometry according to previously described procedures [19] . The mass spectra of intact SDF-1␣ (1-68) and des-lys SDF-1␣ (1-67) are shown in Figure 4A . Masses of 7,962 and 7,833 were observed for the intact and truncated forms of SDF-1␣, respectively, and the difference in masses corresponded to the cleavage of the C-terminal lysine residue. Figure 4B shows the decay 
Cleavage of SDF-1␣ by CPM Abrogates Chemotaxis
Having shown that SDF-1␣ (1-68) is cleaved by CPM to yield the truncated form des-lys SDF-1␣ (1-67), we examined whether the chemotactic response of CD34 ϩ cells (from BM and CB) to full-length SDF-1␣ (1-68) is different from that of CPM-treated SDF-1␣ (1-67). To convert SDF-1␣ (1-68) to SDF-1␣ (1-67), we used the same conditions as described in Figure 4A prior to the chemotaxis assay. We found that chemotaxis was reduced by 43% for CD34 ϩ cells from BM and by a similar degree (38%) for CD34 ϩ cells from CB. We observed that the extent of inhibition of chemotaxis of the CB CD34 ϩ cell samples depended on the chemotactic index, which varied from sample to sample (data not shown). To confirm that cleavage of SDF-1␣ by CPM is the cause of the decrease in chemotactic response, we used an active-site carboxypeptidase antagonist, MERGETPA. Preincubation of recombinant CPM with this Figure 3 . Effect of granulocyte-colony-stimulating factor (G-CSF) on gene and protein expression of CPM. Gene expression was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) using GAPDH as internal mRNA loading con, lysate protein expression was examined by Western blot, and surface protein expression was examined by flow cytometry. (A): MNC from mPB (n ϭ 4) and CB samples (n ϭ 3; shown here are two samples, CB1 and CB2) were incubated without (con) or with 100 ng/ml G-CSF (ϩG) for 24 hours at 37°C in a humidified atmosphere with 5% CO 2 . THP-1 was used as positive con in the Western blot, and equal amounts of lysate proteins were loaded as determined by Bio-Rad assay. (B): Similarly, PMN isolated from the whole blood of normal donors (n ϭ 5) were incubated without (con) or with 100 ng/ml G-CSF (ϩG) for 24 -48 hours at 37°C in a humidified atmosphere with 5% CO 2 , and the expression of CPM transcript was examined by RT-PCR. The numbers at the bottom of the gel indicate fold increase in expression relative to the con. Surface expression of CPM in PMN is shown by flow cytometry. The red line represents con cells, the blue line represents cells stimulated with G-CSF, and the gray area represents isotypic con. (C): RT-PCR analysis of CPM expression in CD34 ϩ cells from BM (n ϭ 2), mPB (n ϭ 7), and CB (n ϭ 2) and BM-derived CFU-F (n ϭ 6) incubated without (con) or with 100 ng/ml G-CSF (ϩG) for 24 hours at 37°C. The numbers at the bottom indicate fold increase in expression relative to the con. For fluorescence-activated cell sorting analysis, mPB CD34 ϩ cells (n ϭ 3) were labeled after incubation with or without 100 ng/ml G-CSF. The red line in the histograms corresponds to con cells, the blue line to cells treated with G-CSF, and the shaded gray area to the isotype con. (D): CPM expression was also analyzed in the granulocyte population of two representative leukapheresis products (G-CSF-mobilized patients; n ϭ 4). The red line corresponds to CPM expression and the shaded blue area to the isotype con. Abbreviations: BM, bone marrow; CB, cord blood; CFU-F, colony-forming unit-fibroblasts; con, control; CPM, carboxypeptidase M; ϩG, with 100 ng/ml granulocyte-colony-stimulating factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MNC, mononuclear cells; mPB, mobilized peripheral blood; PMN, polymorphonuclear cells.
inhibitor (5 M) prior to the SDF-1␣ chemotaxis assay resulted in the preservation of the chemotactic activity of SDF-1␣ on CD34 ϩ cells (Fig. 5A) . MERGETPA alone did not influence the migration toward SDF-1␣ (1-68) (data not shown).
To confirm that it is indeed the cleavage of C-terminal lysine that leads to the decrease in chemotactic response, the other isoform of SDF-1, namely SDF-1␤, whose amino acid sequence shows four more amino acids at the C terminus, ending with methionine in contrast to lysine in SDF-1␣, was used. For this experiment we used CXCR4-expressing Jurkat cells and found that CPM treatment of SDF-1␣ resulted in reduced chemotactic response, whereas CPM treatment of SDF-1␤ had no effect (Fig. 5B) . This was expected, given that SDF-1␤ lacks a C-terminal lysine residue and therefore is not a substrate for CPM.
Furthermore, to examine whether inhibition of CPM on the surface of cells migrating toward SDF-1␣ alters their chemotactic response, we incubated THP-1 cells highly expressing CPM with MERGETPA. We found that cell migration toward SDF-1␣ (1-68) increased by a factor of 1.4 Ϯ 0.1 (p ϭ .05), whereas no effect on chemotaxis toward already cleaved SDF-1␣ (1-67) was observed (Fig. 5C ). The effect on migration was more pronounced when nonsaturating concentrations of SDF-1␣ (1-68) were used (data not shown).
CPM-Cleaved SDF-1␣ Interacts Differently with CXCR4
In our attempt to understand why chemotactic response toward cleaved SDF-1␣ (1-67) is lower compared with full-length SDF-1␣ (1-68), we performed a competitive binding assay using phycoerythrin-conjugated anti-CXCR4 monoclonal antibody (MoAb) (12G5). It was previously shown that the 12G5 clone competes with SDF-1 in binding to its receptor CXCR4 [33] . For this set of experiments we used Jurkat cells, which highly express CXCR4, and exposed them to increasing doses of native full-length SDF-1␣ (1-68) and CPM-treated SDF-1␣ (1-67) at 4°C (to prevent internalization) and using a constant concentration of 12G5 MoAb. The amount of 12G5 bound to cell surface was measured by FACS analysis. Native full-length SDF-1␣ (control) and CPM-treated SDF-1␣ (1-67) were able to compete with 12G5, resulting in reduced binding of 12G5 to the cell surface in a dose-dependent manner (Fig. 6A) . However, the binding of 12G5 to the cell surface was significantly higher with CPM-treated SDF-1␣ (Fig. 6B) , suggesting that truncated SDF-1␣ (1-67) did not compete as efficiently for CXCR4. This may provide some explanation of the reduced chemotactic response shown in Figure 5A .
DISCUSSION
In this study we demonstrated for the first time that CPM is broadly and ubiquitously expressed by cells constituting the BM microenvironment. CPM transcript was present in CD34 ϩ HSPC, hematopoietic progenitors (CFU-Meg, BFU-E, and CFU-GM), MNC, and PMN. However, CPM protein was expressed at higher levels by more mature myeloid precursors, as well as mature monocytes and granulocytes. We also detected CPM transcript in BM stromal cells, as well as in MSC. Detection of CPM transcripts in MSC is consistent with a recent report in which the CPM gene was identified as one of those upregulated during osteogenesis and adipogenesis in MSC derived from BM and adipose tissue, indicating its role in differentiation [35] .
As CPM was first identified and named for its "membranebound" characteristic [36] , we also show here the cell surface localization of this enzyme. In view of its membrane distribution and subcellular localization, CPM may be ideally situated to modulate the activity and potentially participate in the degradation of extracellular proteins and peptides in the BM microenvironment. One of the most abundant peptides in the BM is the chemokine SDF-1; in fact, BM stromal cells constitutively produce approximately 0.8 g/ml (0.1 M) SDF-1, as measured from cultured cells [14] . Endogenous SDF-1 provides a potent retention signal for HSPC, and it has been postulated that degradation of SDF-1 in the BM facilitates the mobilization of these cells to the PB [22] [23] [24] [25] . The ␣ isoform of SDF-1 possesses a lysine C-terminal residue, which makes it a potential substrate for basic carboxypeptidases. Here we show for the first time that CPM cleaves the C-terminal lysine of SDF-1␣. Recently, another carboxypeptidase, CPN, identified in human plasma and serum, was also reported to specifically remove the C-terminal lysine of SDF-1␣ [16, 17] .
We found that cleavage of its C-terminal lysine resulted in a significant decrease in the chemoattractant activity of SDF-1␣ (1-68). The role of the C terminus in chemotaxis has been investigated in a recent study demonstrating that a mutated form of SDF-1␣ with a defective C-terminal ␣-helix (but a normal N terminus) failed to activate cellular signaling and chemotaxis even though the binding affinity was retained [37] . In addition to SDF-1␣ and SDF-1␤, four other human SDF-1 isoforms have recently been identified, all of which stimulated cell migration to various degrees and whose amino acid sequences differed from that of SDF-1␣ only by a few amino acids in the C terminus [38] . Taken together, these results suggest that the C terminus of SDF-1␣ plays an important role in eliciting a chemotactic response.
The presence of CPM in the BM microenvironment takes on greater significance with our finding that the mobilization agent G-CSF strongly upregulates CPM in MNC and PMN. Several other proteases (e.g., elastase, cathepsin G, and MMP-9) are known to be released in large amounts in the BM, particularly by neutrophils, during mobilization induced by G-CSF [22, 23] . Recently, the serine protease DPPIV (CD26) was also shown to be induced during mobilization of murine HSPC [39] . Furthermore, short-term in vitro G-CSF treatment upregulated CD26, resulting in downregulation of the functional ability of CB CD34 ϩ HSPC to respond to an SDF-1␣ gradient [40] . We suggest that CPM present on the cell surface of hematopoietic and stromal cells may participate in a more subtle way to alter the SDF-1␣ gradient that keeps the HSPC within the BM niches. This idea is strengthened by our observations that inhibition of carboxypeptidase activity on cells expressing CPM (THP-1 cells) enhanced cell migration toward SDF-1␣ (1-68). As it has been suggested that the C-terminal lysine of SDF-1␣ contributes to its binding with heparin on the cell surface, preserving the activity of SDF-1␣ [17] , we propose that CPM cleavage of lysine could facilitate the release of SDF-1␣ from the cell surface and its further degradation by various proteases. Because SDF-1 is constitutively expressed by BM stromal cells, its controlled degradation becomes even more important in regulation of its biological functions.
To explain the abrogated chemotactic response of des-lys SDF-1␣, we investigated whether there is a difference in the nature of the interaction of full-length (1-68) and CPM-treated SDF-1␣ (1-67) with CXCR4. Binding of SDF-1␣ to CXCR4 involves several parts of the receptor: the N-terminal region and the extracellular loops (ECL) 2 and 3. The N-terminal domain and ECL3 are determinants for ligand binding, whereas ECL2 is considered important for receptor signaling. The MoAb 12G5 recognizes a conformational epitope of ECL2 that is present on CXCR4 and disappears when SDF1-␣ binds [41, 42] . Therefore, our results suggest that following the initial binding, there is an effect of the C-terminal lysine on conformational changes related to receptor triggering that is reflected in the chemotaxis results.
SUMMARY
We show in this work that (a) CPM is widely expressed by cells of the BM microenvironment, (b) G-CSF strongly upregulates its expression in MNC and PMN, and (c) CPM cleaves the C-terminal lysine of SDF-1␣, which abrogates the chemotactic response. Thus, CPM may participate with other proteases in modulating the SDF-1␣/CXCR4 axis and may therefore be implicated in HSPC mobilization.
